Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 654 across all filing types
Latest filing 2025-07-17 Interim / Quarterly Rep…
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport Q2 / 2025' (Interim Report Q2 2025) for Vitrolife AB. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on performance for the second quarter and the first half of 2025. It is a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report. Q2 2025
2025-07-17 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report Q2 / 2025' and contains comprehensive financial statements, including net sales, EBITDA, net income, earnings per share, and cash flow analysis for the second quarter and first half of 2025. It provides detailed management commentary on business performance, regional segments, and strategic updates. As it is a substantive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q2 2025
2025-07-17 English
Kommuniké från årsstämma i Vitrolife AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kommuniké från årsstämma i Vitrolife AB (publ)" which translates to "Announcement from the Annual General Meeting (AGM) in Vitrolife AB (publ)". The content details specific resolutions passed at the meeting, including decisions on dividend distribution, re-election of board members, board remuneration, auditor reappointment, and authorizations for share issues/repurchases. These are classic outcomes of an AGM. Since the document summarizes the decisions made *at* the meeting rather than being a proxy statement (PSI) or a formal voting result declaration (DVA), and it is explicitly an announcement of the AGM outcomes, the most appropriate classification is AGM Information (AGM-R). The document length is short (2678 chars), but it is the substance of the meeting's results, not just an announcement that a report is available.
2025-04-30 Swedish
Report from Annual General Meeting of Vitrolife AB (publ)
AGM Information Classification · 99% confidence The document is explicitly titled 'Report from Annual General Meeting of Vitrolife AB (publ)' and details resolutions passed at this meeting, including dividend approval, board member re-elections, remuneration details, and authorizations for share issuance/acquisition. This content directly corresponds to the materials presented or decided upon during an Annual General Meeting (AGM). Therefore, the classification should be AGM Information (AGM-R). The document is not a short announcement about a report (RPA/RNS), but the report content itself.
2025-04-30 English
Kommuniké från årsstämma i Vitrolife AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kommuniké från årsstämma i Vitrolife AB (publ)" which translates to "Communication from the Annual General Meeting (AGM) in Vitrolife AB (publ)". The text details specific resolutions passed at the meeting, including decisions on dividend distribution, re-election of board members, board remuneration, auditor appointment, and authorizations for share issuance/repurchase. These are classic outcomes and announcements following an AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document length is short (2588 chars), but it contains the substantive decisions, not just an announcement that the results are available elsewhere, making AGM-R more specific than RPA or RNS.
2025-04-29 Swedish
Report from Annual General Meeting of Vitrolife AB (publ)
AGM Information Classification · 99% confidence The document is explicitly titled 'Report from Annual General Meeting of Vitrolife AB (publ)' and details resolutions passed at this meeting, such as dividend approval, board member re-election, remuneration changes, and authorizations for share issuance/acquisition. These are core components of an AGM outcome report. Therefore, the classification should be AGM-R (AGM Information). The document is not a short announcement about a report (RPA/RNS), but the actual summary of the meeting's decisions.
2025-04-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.